• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Polo-like kinase-1 在 Ser260 位点使 MDM2 磷酸化,并刺激 MDM2 介导的 p53 周转。

Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover.

机构信息

Biomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, United Kingdom.

出版信息

FEBS Lett. 2009 Nov 19;583(22):3543-8. doi: 10.1016/j.febslet.2009.09.057. Epub 2009 Oct 13.

DOI:10.1016/j.febslet.2009.09.057
PMID:19833129
Abstract

The E3 ubiqutin ligase, murne double-minute clone 2 (MDM2), promotes the degradation of p53 under normal homeostatic conditions. Several serine residues within the acidic domain of MDM2 are phosphorylated to maintain its activity but become hypo-phosphorylated following DNA damage, leading to inactivation of MDM2 and induction of p53. However, the signalling pathways that mediate these phosphorylation events are not fully understood. Here we show that the oncogenic and cell cycle-regulatory protein kinase, polo-like kinase-1 (PLK1), phosphorylates MDM2 at one of these residues, Ser260, and stimulates MDM2-mediated turnover of p53. These data are consistent with the idea that deregulation of PLK1 during tumourigenesis may help suppress p53 function.

摘要

E3 泛素连接酶、鼠双微基因 2(MDM2)在正常的体内平衡条件下促进 p53 的降解。MDM2 的酸性结构域内的几个丝氨酸残基被磷酸化以保持其活性,但在 DNA 损伤后变得低磷酸化,导致 MDM2 失活和 p53 的诱导。然而,介导这些磷酸化事件的信号通路尚不完全清楚。在这里,我们表明致癌和细胞周期调节蛋白激酶,类 polo 激酶-1(PLK1),在这些残基之一 Ser260 上磷酸化 MDM2,并刺激 MDM2 介导的 p53 周转。这些数据与肿瘤发生过程中 PLK1 的失调可能有助于抑制 p53 功能的观点一致。

相似文献

1
Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover.Polo-like kinase-1 在 Ser260 位点使 MDM2 磷酸化,并刺激 MDM2 介导的 p53 周转。
FEBS Lett. 2009 Nov 19;583(22):3543-8. doi: 10.1016/j.febslet.2009.09.057. Epub 2009 Oct 13.
2
Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover.蛋白激酶CK1δ使小鼠双微体克隆2蛋白(MDM2)酸性结构域中的关键位点发生磷酸化,这些位点可调节p53的周转。
Biochemistry. 2004 Dec 28;43(51):16356-64. doi: 10.1021/bi0489255.
3
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.DNA损伤后,ATM和Chk2依赖的MDMX磷酸化有助于p53激活。
EMBO J. 2005 Oct 5;24(19):3411-22. doi: 10.1038/sj.emboj.7600812. Epub 2005 Sep 15.
4
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.Wip1磷酸酶在p53-Mdm2自动调节环路中起把关作用。
Cancer Cell. 2007 Oct;12(4):342-54. doi: 10.1016/j.ccr.2007.08.033.
5
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.Hdmx的磷酸化介导其在DNA损伤响应中依赖Hdm2和ATM的降解。
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5056-61. doi: 10.1073/pnas.0408595102. Epub 2005 Mar 23.
6
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.ATM 对 Daxx 的磷酸化有助于 DNA 损伤诱导的 p53 激活。
PLoS One. 2013;8(2):e55813. doi: 10.1371/journal.pone.0055813. Epub 2013 Feb 6.
7
Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.蛋白激酶CK2在体外及培养细胞中使小鼠双微体克隆2(MDM2)蛋白的丝氨酸-267位点发生磷酸化。
Biochem J. 2001 Apr 15;355(Pt 2):347-56. doi: 10.1042/0264-6021:3550347.
8
Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.蛋白激酶CK2对Mdm2酸性结构域的磷酸化作用。
Mol Cell Biochem. 2005 Jun;274(1-2):85-90. doi: 10.1007/s11010-005-3074-4.
9
The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.人类痘苗病毒相关激酶1(VRK1)使p53肿瘤抑制蛋白的mdm-2结合位点内的苏氨酸-18发生磷酸化。
Oncogene. 2000 Jul 27;19(32):3656-64. doi: 10.1038/sj.onc.1203709.
10
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.丝氨酸395处Mdm2的ATM依赖性磷酸化:在DNA损伤激活p53中的作用
Genes Dev. 2001 May 1;15(9):1067-77. doi: 10.1101/gad.886901.

引用本文的文献

1
Only Infant -Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib.仅婴儿重排型白血病对沃拉替尼抑制波罗样激酶1(PLK-1)敏感。
Int J Mol Sci. 2024 Nov 27;25(23):12760. doi: 10.3390/ijms252312760.
2
Biomarkers of Alzheimer's Disease Associated with Programmed Cell Death Reveal Four Repurposed Drugs.与细胞程序性死亡相关的阿尔茨海默病生物标志物揭示了四种重新定位的药物。
J Mol Neurosci. 2024 May 3;74(2):51. doi: 10.1007/s12031-024-02228-0.
3
Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer.
维持基因组完整性:蛋白激酶和磷酸酶在癌症中协调 DNA 双链断裂修复的平衡作用。
Int J Mol Sci. 2023 Jun 16;24(12):10212. doi: 10.3390/ijms241210212.
4
Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.三阴性乳腺癌关键基因的生物信息学分析及癌基因PLK1的验证
Ann Transl Med. 2020 Dec;8(24):1637. doi: 10.21037/atm-20-6873.
5
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.在TP53突变的肝细胞癌中对Polo样激酶1和含杆状病毒凋亡重复序列蛋白5进行双重靶向作用
World J Gastroenterol. 2020 Aug 28;26(32):4786-4801. doi: 10.3748/wjg.v26.i32.4786.
6
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Notch 介导的致癌性 PLK1 抑制在 B 细胞急性淋巴细胞白血病中的抗白血病作用。
Mol Cancer Ther. 2019 Sep;18(9):1615-1627. doi: 10.1158/1535-7163.MCT-18-0706. Epub 2019 Jun 21.
7
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?有丝分裂癌症靶点 Polo 样激酶 1:癌基因还是肿瘤抑制因子?
Genes (Basel). 2019 Mar 11;10(3):208. doi: 10.3390/genes10030208.
8
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.TAK-960 对结直肠癌临床前模型的抗肿瘤活性。
BMC Cancer. 2018 Feb 5;18(1):136. doi: 10.1186/s12885-018-4036-z.
9
The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.Polo样激酶1在上皮-间质转化和肿瘤转移中的新作用
Cancers (Basel). 2017 Sep 27;9(10):131. doi: 10.3390/cancers9100131.
10
PLK1, A Potential Target for Cancer Therapy.PLK1,一种癌症治疗的潜在靶点。
Transl Oncol. 2017 Feb;10(1):22-32. doi: 10.1016/j.tranon.2016.10.003. Epub 2016 Nov 24.